ACRV
Acrivon Therapeutics·NASDAQ
--
--(--)
--
--(--)
ACRV fundamentals
Acrivon Therapeutics (ACRV) released its earnings on Nov 13, 2025: revenue was 0 (YoY 0.00%), met estimates; EPS was -0.47 (YoY +20.34%), beat estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-0.47
+20.34%
Report date
Nov 13, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Acrivon Therapeutics (ACRV) key financial stats and ratios, covering profitability, financial health, and leverage.
Acrivon Therapeutics (ACRV)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Acrivon Therapeutics (ACRV)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Acrivon Therapeutics (ACRV)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Acrivon Therapeutics (ACRV) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Acrivon Therapeutics (ACRV) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did Acrivon Therapeutics's management provide for the next earnings period?Did Acrivon Therapeutics beat or miss consensus estimates last quarter?What is the market's earnings forecast for Acrivon Therapeutics next quarter?What does Acrivon Therapeutics do and what are its main business segments?What is Acrivon Therapeutics's gross profit margin?What is Acrivon Therapeutics's latest dividend and current dividend yield?What were the key takeaways from Acrivon Therapeutics's earnings call?What were the key takeaways from Acrivon Therapeutics’s earnings call?
